CYPHERPUNK TECHNOLOGIES INC. Other Non-Current Assets
CYPHERPUNK TECHNOLOGIES INC. (CYPH) had Other Non-Current Assets of $15.00 thousand as of 2023-03-31, per its 10-Q filed 2023-05-15.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OtherAssetsNoncurrent · last filed 2024-03-18
- 2023-03-31: Other Assets, Noncurrent $15.00K.
- 2022-12-31: Other Assets, Noncurrent $30.00K.
- 2022-09-30: Other Assets, Noncurrent $45.00K.
- 2022-06-30: Other Assets, Noncurrent $60.00K.
| Period end | Other Assets, Noncurrent |
|---|---|
| 2023-03-31 | $15.00K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $30.00K 10-K · filed 2024-03-18 |
| 2022-09-30 | $45.00K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $60.00K 10-Q · filed 2022-08-12 |
| 2022-03-31 | $75.00K 10-Q · filed 2022-05-13 |
| 2021-12-31 | $90.00K 10-K · filed 2023-03-24 |
| 2019-09-30 | $1.46M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $1.52M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $1.52M 10-Q · filed 2019-05-15 |
| 2018-12-31 | $1.54M 10-Q · filed 2019-11-14 |
| 2018-09-30 | $1.37M 10-Q · filed 2018-11-09 |
| 2018-06-30 | $1.25M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $1.11M 10-Q/A · filed 2018-08-08 |
| 2017-12-31 | $1.11M 10-K · filed 2019-04-01 |
| 2017-09-30 | $930.00K 10-Q · filed 2017-11-13 |
| 2017-06-30 | $937.00K 10-Q · filed 2017-08-11 |
| 2017-03-31 | $937.00K 10-Q · filed 2017-05-12 |
| 2016-12-31 | $907.00K 10-K · filed 2018-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |